This Annual Evaluation Plan is one of several required Evidence Act products, including the 4-year Evidence-Building Plan (also referred to as the Learning Agenda), Capacity Assessment, and agency Evaluation Policy. The FY2023 Evaluation Plan priority areas are aligned with the goals of the FY 2022-2026 HHS Strategic Plan and the FY 2023- 2026 HHS Evidence-Building Plan.
Evaluation
Evaluation and analysis provide essential evidence for HHS to understand how its programs work, for whom, and under what circumstances. HHS builds evidence through evaluation and analysis in order to inform decisions in budget, legislative, regulatory, strategic planning, program, and policy arenas. Given the breadth of work supported by HHS, many evaluations and analyses are conducted each year. These efforts range in scope, scale, design, and methodology, but all aim to understand how the effect of programs and policies and how they can be improved.
Across HHS, evaluation comes in many forms, including:
- Program evaluations using the most rigorous designs appropriate;
- Capacity-building initiatives to improve administrative data collection, accessibility, and use for management;
- Exploratory and preliminary quantitative and qualitative analysis to build evidence;
- Pilots and demonstrations; and
- Statistical analysis of factors related to health and human services programs and policies.
ASPE coordinates the evaluation community by regularly convening the HHS Evaluation & Evidence Policy Council, which builds capacity by sharing best practices and promising new approaches across HHS.
Reports
Displaying 31 - 40 of 348. 10 per page. Page 4.
Advanced SearchReport
FY 2023-2026 HHS Capacity Assessment
March 28, 2022
Under the Foundations for Evidence-Based Policymaking Act of 2018 (Evidence Act), the Capacity Assessment requires agencies to assess the coverage, quality, methods, effectiveness, and independence of their statistics, evaluation, research, and analysis efforts.
Report
FY 2023-2026 HHS Evidence-Building Plan
March 28, 2022
The HHS Evidence Building Plan, required by the Evidence Act, is a systematic plan for identifying and addressing policy questions relevant to the programs, policies, and regulations of the agency.
Program Evaluation, Report
Interim Cost and Quality Findings from the National Evaluation of the Certified Community Behavioral Health Clinic Demonstration
December 23, 2021
This report outlines interim findings from the evaluation of the Certified Community Behavioral Health Clinic (CCBHC) evaluation.
Report
Certified Community Behavioral Health Clinics Demonstration Program: Report to Congress, 2020
December 23, 2021
This is the fourth annual report to Congress describing results from the Certified Community Behavioral Health Clinic (CCBHC) evaluation. This report summarizes changes in CCBHC rates and costs from demonstration year one (DY1) to DY2, performance on quality measures in DY1, and the extent to which states provided quality bonus payments (QBPs) to CCBHCs for DY1.
Research Brief
COVID-19 Vaccination Associated with Reductions in COVID-19 Mortality and Morbidity in the United States, and an Approach to Valuing these Benefits
December 15, 2021
This ASPE Research Report models the estimated reductions in COVID-19 cases, hospitalizations, and deaths associated with COVID-19 vaccination from December 2020 through July 2021. To download the Research Report, please download the PDF to the right under “Files”. To explore our dashboard that presents the Report’s results, please see below.
ASPE Issue Brief
Participation in the U.S. Social Safety Net: Coverage of Low-income Families, 2018
November 24, 2021
Participation in the social safety net varies widely across programs—from 15 percent among eligibles for subsidized child care (CCDF) to over 75 percent for Medicaid/CHIP and EITC.
Participation differs by race and ethnicity, yet patterns are not consistent. In general rates differ more across programs than between race-ethnic groups.
Report
Comparing Outcomes for Dual Eligible Beneficiaries in Integrated Care: Final Report
October 22, 2021
Dual eligible beneficiaries are an important subset of the Medicare and Medicaid populations because they have a high prevalence of chronic conditions and disabilities, substantial care needs, and high health care and long-term services and supports (LTSS) utilization and costs.
Report
Addressing Uncertainty in Regulatory Impact Analysis
October 15, 2021
In 2016, the U.S. Department of Health and Human Services finalized its Guidelines for Regulatory Impact Analysis under the leadership of its Assistant Secretary for Planning Evaluation and Analytics Team. The Guidelines discuss strategies for characterizing the uncertainty in quantified effects as well as the potential impacts of non-quantified effects.
Research Brief
Associations Between County-level Vaccination Rates and COVID-19 Outcomes Among Medicare Beneficiaries in Early 2021
October 5, 2021
The purpose of this study is to identify associations between COVID-19 infections, hospitalizations, and deaths among Medicare fee-for-service (FFS) beneficiaries and the proportion of the population fully vaccinated at the county-level between January and May 2021.